Amlodipine Better BP Drug for Lower Long-Term Risk for Gout
TUESDAY, Feb. 18, 2020 -- The antihypertensive medication amlodipine is associated with a lower risk for gout compared with other antihypertensive agents, according to a study published online Jan. 20 in the Journal of Hypertension. Stephen P.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 18, 2020 Category: Pharmaceuticals Source Type: news

Debates in Gout Management Debates in Gout Management
This review provides an update on the most current research that may impact gout management.Current Opinion in Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 13, 2020 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Could Colchicine Be the New Aspirin? Could Colchicine Be the New Aspirin?
Michel Zeitouni talks to Jean-Claude Tardif about the COLCOT series of clinical trials testing colchicine, an anti-inflammatory gout drug, for the prevention and treatment of cardiovascular disease.theheart.org on Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 27, 2020 Category: Consumer Health News Tags: Cardiology Expert Interview Source Type: news

Blood pressure drug linked to lower risk of gout
(Beth Israel Deaconess Medical Center) A new study led by physician-researchers at Beth Israel Deaconess Medical Center (BIDMC) reports that the antihypertensive drug amlodipine lowered long-term gout risk compared to two other drugs commonly prescribed to lower blood pressure. The findings are published in the Journal of Hypertension. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 27, 2020 Category: International Medicine & Public Health Source Type: news

Certain Diabetes Meds May Lower Gout Risk, Too
Title: Certain Diabetes Meds May Lower Gout Risk, TooCategory: Health NewsCreated: 1/13/2020 12:00:00 AMLast Editorial Review: 1/14/2020 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - January 14, 2020 Category: Rheumatology Source Type: news

Diabetes Drug Class May Hold Promise for Gout Prevention Diabetes Drug Class May Hold Promise for Gout Prevention
Adults with type 2 diabetes prescribed an SGLT2 inhibitor were less likely to develop gout than those prescribed a GLP-1 receptor agonist.Medscape Medical News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - January 13, 2020 Category: Primary Care Tags: Diabetes & Endocrinology News Source Type: news

Gout Incidence Down With SGLT2 Inhibitors in Type 2 Diabetes
MONDAY, Jan. 13, 2020 -- Adults with type 2 diabetes newly prescribed a sodium-glucose cotransporter-2 (SGLT2) inhibitor have a lower incidence of gout than those prescribed a glucagon-like peptide-1 (GLP-1) receptor agonist, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 13, 2020 Category: Pharmaceuticals Source Type: news

Certain Diabetes Meds May Lower Gout Risk, Too
MONDAY, Jan. 13, 2020 -- Medications called SGLT2 inhibitors lower blood sugar in people with type 2 diabetes. And new research suggests these drugs may have an added benefit -- lowering the risk of gout. Compared with people taking another class... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 13, 2020 Category: General Medicine Source Type: news

Ultrasonographic Features of Lower-Limb Joints in Gout Ultrasonographic Features of Lower-Limb Joints in Gout
Find out which ultrasound features might be helpful for the diagnosis of gout, particularly in the lower extremity joints.Journal of Clinical Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 9, 2020 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Gout and Hyperuricaemia in the USA: Prevalence and Trends Gout and Hyperuricaemia in the USA: Prevalence and Trends
The global prevalence of gout and hyperuricemia is on the rise. Have these same trends been observed in the U.S.?Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 3, 2020 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

How your height can show your risk of cancer and heart disease
The size of various parts of our body is now known to provide clues about whether we're at risk from a range of diseases, including gout, high blood pressure, heart disease and even cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - December 31, 2019 Category: Consumer Health News Source Type: news

Wearable sweat sensor detects gout-causing compounds
(California Institute of Technology) Caltech's Wei Gao has developed an easier way to mass-produce highly sensitive sweat sensors that can detect a variety of low-concentration compounds related to health conditions (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 25, 2019 Category: International Medicine & Public Health Source Type: news

Drug used to treat gout cuts odds of new heart attack, stroke in heart attack survivors
The inflammation-fighting drug colchicine, already a treatment for gout, dramatically reduces the odds of future cardiovascular problems in people who have just survived a heart attack, a large new study by a Montreal researcher has concluded. (Source: CBC | Health)
Source: CBC | Health - November 18, 2019 Category: Consumer Health News Tags: News/Health Source Type: news

Colchicine cuts odds of new heart attack, stroke in heart attack survivors
(Reuters Health) - The inflammation-fighting drug colchicine, already a treatment for gout, dramatically reduces the odds of future cardiovascular problems in people who have just survived a heart attack, a large new study has concluded. (Source: Reuters: Health)
Source: Reuters: Health - November 18, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Cheap, Older Gout Drug Could Be a Lifesaver After Heart Attack
In the new trial, colchicine reduced by as much as 34% a heart attack survivor's combined risk of either dying from heart disease or having cardiac arrest, a heart attack, a stroke or angioplasty. (Source: WebMD Health)
Source: WebMD Health - November 18, 2019 Category: Consumer Health News Source Type: news